Intellectual Property India Publishes Patent Application for 'Recombinant Expression Vector For Production Of Virus-Like Particle-Based Multivalent Norovirus Vaccine And Manufacturing Method Therefor' Filed by Inthera Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517099274 A) filed by Inthera Inc., Seoul, Republic of Korea, on Oct. 14, for 'recombinant expression vector for production of virus-like particle-based multivalent norovirus vaccine and manufacturing method therefor.'

Inventor(s) include Choi, Deog Young; and Jung, Hyun Gyo.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides a fusion protein for promoting soluble expression of a norovirus antigen, and an expression vector thereof. More specifically, the present invention provides combinations of various genotypes ...